Blenrep TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: belantamab mafodotin
Brand name
(ARTG)
: BLENREP belantamab mafodotin 100 mg powder for injection vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
BLENREP is indicated for the treatment of adults with relapsed or refractory multiple myeloma:,in combination with bortezomib and dexamethasone in patients who have received at least one prior therapy; and,in combination with pomalidomide and dexamethasone in patients who have received at least one prior therapy including lenalidomide.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Intravenous Infusion
- Powder for injection,Each vial contains belantamab mafodotin as a lyophilised white to yellow powder.
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Store in Original Container
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient belantamab mafodotin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
